Martoma Got Tips From Two Doctors, Prosecutors Say

Aug 23 2013 | 5:34am ET

Former SAC Capital Advisors portfolio Mathew Martoma received confidential information from at least two doctors, prosecutors alleged in a revised indictment.

Martoma is accused of earning SAC hundreds of millions of dollars trading on tips about drug trials—allegations that are also part of the criminal case against the hedge fund itself.

One of his alleged sources, former University of Michigan medical professor Sidney Gilman, has admitted tipping Martoma and is cooperating with prosecutors. But the superseding indictment refers to a second doctor as a co-conspirator, although that person is not named.

As with Gilman, Martoma allegedly made contact with the second doctor through an expert network. The doctor, according to prosecutors, passed Martoma non-public information “with the expectation that Martoma would assist in obtaining additional clinical trial business.”

Martoma also e-mailed more than 20 doctors working on the clinical trial that Gilman was overseeing.

The new indictment could be an effort by the government to push Martoma to cooperate in the case against SAC. Martoma has pleaded not guilty and has thus far spurned approaches to turn on his former employer.

In the new indictment, prosecutors said that Martoma should forfeit at least $9.3 million, including his home in Boca Raton, Fla., and as much as $13.7 million.


In Depth

Kettera Q&A: The Advantages of Alternative Investment Platforms

Oct 28 2016 | 5:52pm ET

The past several years have seen a distinct push towards easier and cheaper access...

Lifestyle

Midtown's Plaza District Fades As Manhattan Office Landscape Shifts

Nov 22 2016 | 6:32pm ET

Lower leasing costs, more efficient office space and the hope of projecting an image...

Guest Contributor

Nowhere to Hide: Why the Future of Asset Management Depends on Innovation

Nov 15 2016 | 6:55pm ET

Information technology has reshaped the asset management industry’s periphery,...

 

From the current issue of

Chicago-based independent futures brokerage and clearing firm R.J. O’Brien & Associates (RJO) has hired industry veteran Daniel Staniford as Executive Director, responsible for the firm’s institutional business development in New York and London.

AVAILABLE NOW at BARNES & NOBLE

NEWSTAND LOCATOR